Nathaniel A Cohen1, David T Rubin. 1. The University of Chicago Medicine Inflammatory Bowel Disease Center, Chicago, Illinois, USA.
Abstract
PURPOSE OF REVIEW: In the rapidly progressing world of inflammatory bowel disease, this review discusses and summarizes new drug targets and results from major clinical trials in order to provide an update to physicians treating patients with inflammatory bowel diseases (IBD). RECENT FINDINGS: Multiple new mechanisms in the treatment of IBD are being developed and many are showing promising results in both ulcerative colitis and Crohn's disease patients. In addition to efficacy, some of these treatments may provide safety benefits over existing therapies. SUMMARY: The IBD physicians' therapeutic armamentarium is rapidly expanding and keeping abreast of these developments is required in order to provide patients with optimized individualized care.
PURPOSE OF REVIEW: In the rapidly progressing world of inflammatory bowel disease, this review discusses and summarizes new drug targets and results from major clinical trials in order to provide an update to physicians treating patients with inflammatory bowel diseases (IBD). RECENT FINDINGS: Multiple new mechanisms in the treatment of IBD are being developed and many are showing promising results in both ulcerative colitis and Crohn's disease patients. In addition to efficacy, some of these treatments may provide safety benefits over existing therapies. SUMMARY: The IBD physicians' therapeutic armamentarium is rapidly expanding and keeping abreast of these developments is required in order to provide patients with optimized individualized care.
Authors: Kim A Papp; Andrew Blauvelt; Michael Bukhalo; Melinda Gooderham; James G Krueger; Jean-Philippe Lacour; Alan Menter; Sandra Philipp; Howard Sofen; Stephen Tyring; Beate R Berner; Sudha Visvanathan; Chandrasena Pamulapati; Nathan Bennett; Mary Flack; Paul Scholl; Steven J Padula Journal: N Engl J Med Date: 2017-04-20 Impact factor: 91.245
Authors: W J Sandborn; S B Hanauer; P Rutgeerts; R N Fedorak; M Lukas; D G MacIntosh; R Panaccione; D Wolf; J D Kent; B Bittle; J Li; P F Pollack Journal: Gut Date: 2007-02-13 Impact factor: 23.059
Authors: Geert R D'Haens; Walter Reinisch; Scott D Lee; Dino Tarabar; Edouard Louis; Maria Kłopocka; Jochen Klaus; Stefan Schreiber; Dong Il Park; Xavier Hébuterne; Peter Nagy; Fabio Cataldi; Steven W Martin; Satyaprakash Nayak; Anindita Banerjee; Kenneth J Gorelick; William J Sandborn Journal: Inflamm Bowel Dis Date: 2022-07-01 Impact factor: 7.290
Authors: Brian G Feagan; William J Sandborn; Christopher Gasink; Douglas Jacobstein; Yinghua Lang; Joshua R Friedman; Marion A Blank; Jewel Johanns; Long-Long Gao; Ye Miao; Omoniyi J Adedokun; Bruce E Sands; Stephen B Hanauer; Severine Vermeire; Stephan Targan; Subrata Ghosh; Willem J de Villiers; Jean-Frédéric Colombel; Zsolt Tulassay; Ursula Seidler; Bruce A Salzberg; Pierre Desreumaux; Scott D Lee; Edward V Loftus; Levinus A Dieleman; Seymour Katz; Paul Rutgeerts Journal: N Engl J Med Date: 2016-11-17 Impact factor: 91.245